A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.
New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.
Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.